Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA joint advisory committee meeting recommends against stannsoporfin

May 4, 2018

Phase I trial begins of CS-1002 for advanced solid tumors begins in Australia

May 4, 2018

Dong-A Socio Holdings identifies Mer inhibitors

May 4, 2018

RTI International discovers new APLNR agonists

May 4, 2018

Phase III trial of ranibizumab biosimilar FYB-201 meets primary endpoint

May 4, 2018

Sanofi reviews key events of first quarter 2018

May 4, 2018

Jiangsu Hengrui Medicine and collaborator disclose TGFR-1 inhibitors

May 4, 2018

AbbVie divulges novel BRD4 inhibitors

May 4, 2018

Ferring Pharmaceuticals acquires option to commercialize nadofaragene firadenovec/Syn3

May 4, 2018

Bristol-Myers Squibb presents new apelin receptor agonists

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...